Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Natural Killer and NK-Like T-Cell Activation in Colorectal Carcinoma Patients Treated with Autologous Tumor-Derived Heat Shock Protein 96

Lorenzo Pilla, Paola Squarcina, Jorgelina Coppa, Vincenzo Mazzaferro, Veronica Huber, Daniela Pende, Cristina Maccalli, Gloria Sovena, Luigi Mariani, Chiara Castelli, Giorgio Parmiani, Licia Rivoltini

Cancer Res (2005) 65 (9): 3942–3949.

https://doi.org/10.1158/0008-5472.CAN-04-3493

Published: 02 May 2005

View articletitled, Natural Killer and NK-Like T-Cell Activation in Colorectal Carcinoma Patients Treated with Autologous Tumor-Derived Heat Shock Protein 96

Journal Articles

Human colon carcinoma cells release microvesicles bearing active FasL and TRAIL and affecting tumor/immune interactions.

Veronica Huber, Stefano Fais, Roberta Valenti, Paola Canese, Agata Cova, Gloria Sovena, Paola Squarcina, Manuela Iero, Giuseppe Arancia, Lorenzo Pilla, Giorgio Parmiani, Licia Rivoltini

Cancer Res (2004) 64 (7_Supplement): 504.

Published: 01 April 2004

View articletitled, Human colon carcinoma cells release microvesicles bearing active FasL and TRAIL and affecting tumor/immune interactions.

Journal Articles

Limited cross-recognition of native peptide and HLA-A*0201⁺CEA⁺ colon carcinoma cells by CD8⁺ T cells raised by the superagonist CEA-analogue CAP1-6D

Manuela Iero, Paola Squarcina, Matteo Carrabba, Veronica Huber, Cristina Maccalli, Flavio Arienti, Giorgio Parmiani, Licia Rivoltini

Cancer Res (2004) 64 (7_Supplement): 1264.

Published: 01 April 2004

View articletitled, Limited cross-recognition of native peptide and HLA-A*0201+CEA+ colon carcinoma cells by CD8+ T cells raised by the superagonist CEA-analogue CAP1-6D

Journal Articles

Suboptimal Activation of CD8⁺ T Cells by Melanoma-derived Altered Peptide Ligands: Role of Melan-A/MART-1 Optimized Analogues

Matteo G. Carrabba, Chiara Castelli, Markus J. Maeurer, Paola Squarcina, Agata Cova, Lorenzo Pilla, Nicolina Renkvist, Giorgio Parmiani, Licia Rivoltini

Cancer Res (2003) 63 (7): 1560–1567.

Published: 01 April 2003

View articletitled, Suboptimal Activation of CD8+ T Cells by Melanoma-derived Altered Peptide Ligands: Role of Melan-A/MART-1 Optimized Analogues

Journal Articles

A Superagonist Variant of Peptide MART1/Melan A_27–35 Elicits Anti-Melanoma CD8⁺ T Cells with Enhanced Functional Characteristics: Implication for More Effective Immunotherapy

Licia Rivoltini, Paola Squarcina, Douglas J. Loftus, Chiara Castelli, Paolo Tarsini, Arabella Mazzocchi, Francesca Rini, Vincenzo Viggiano, Filiberto Belli, Giorgio Parmiani

Cancer Res (1999) 59 (2): 301–306.

Published: 15 January 1999

View articletitled, A Superagonist Variant of Peptide MART1/Melan A27–35 Elicits Anti-Melanoma CD8+ T Cells with Enhanced Functional Characteristics: Implication for More Effective Immunotherapy

Journal Articles

Peptides Derived from Self-Proteins as Partial Agonists and Antagonists of Human CD8⁺ T-Cell Clones Reactive to Melanoma/Melanocyte Epitope MART1_27–35

Douglas J. Loftus, Paola Squarcina, Mai-Britt Nielsen, Carsten Geisler, Chiara Castelli, Niels Ødum, Ettore Appella, Giorgio Parmiani, Licia Rivoltini

Cancer Res (1998) 58 (11): 2433–2439.

Published: 01 June 1998

View articletitled, Peptides Derived from Self-Proteins as Partial Agonists and Antagonists of Human CD8+ T-Cell Clones Reactive to Melanoma/Melanocyte Epitope MART127–35

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Natural Killer and NK-Like T-Cell Activation in Colorectal Carcinoma Patients Treated with Autologous Tumor-Derived Heat Shock Protein 96

Human colon carcinoma cells release microvesicles bearing active FasL and TRAIL and affecting tumor/immune interactions.

Limited cross-recognition of native peptide and HLA-A*0201⁺CEA⁺ colon carcinoma cells by CD8⁺ T cells raised by the superagonist CEA-analogue CAP1-6D

Suboptimal Activation of CD8⁺ T Cells by Melanoma-derived Altered Peptide Ligands: Role of Melan-A/MART-1 Optimized Analogues

A Superagonist Variant of Peptide MART1/Melan A_27–35 Elicits Anti-Melanoma CD8⁺ T Cells with Enhanced Functional Characteristics: Implication for More Effective Immunotherapy

Peptides Derived from Self-Proteins as Partial Agonists and Antagonists of Human CD8⁺ T-Cell Clones Reactive to Melanoma/Melanocyte Epitope MART1_27–35

Email alerts

AACR Journals

Update search

Natural Killer and NK-Like T-Cell Activation in Colorectal Carcinoma Patients Treated with Autologous Tumor-Derived Heat Shock Protein 96

Human colon carcinoma cells release microvesicles bearing active FasL and TRAIL and affecting tumor/immune interactions.

Limited cross-recognition of native peptide and HLA-A*0201+CEA+ colon carcinoma cells by CD8+ T cells raised by the superagonist CEA-analogue CAP1-6D

Suboptimal Activation of CD8+ T Cells by Melanoma-derived Altered Peptide Ligands: Role of Melan-A/MART-1 Optimized Analogues

A Superagonist Variant of Peptide MART1/Melan A27–35 Elicits Anti-Melanoma CD8+ T Cells with Enhanced Functional Characteristics: Implication for More Effective Immunotherapy

Peptides Derived from Self-Proteins as Partial Agonists and Antagonists of Human CD8+ T-Cell Clones Reactive to Melanoma/Melanocyte Epitope MART127–35

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Limited cross-recognition of native peptide and HLA-A*0201⁺CEA⁺ colon carcinoma cells by CD8⁺ T cells raised by the superagonist CEA-analogue CAP1-6D

Suboptimal Activation of CD8⁺ T Cells by Melanoma-derived Altered Peptide Ligands: Role of Melan-A/MART-1 Optimized Analogues

A Superagonist Variant of Peptide MART1/Melan A_27–35 Elicits Anti-Melanoma CD8⁺ T Cells with Enhanced Functional Characteristics: Implication for More Effective Immunotherapy

Peptides Derived from Self-Proteins as Partial Agonists and Antagonists of Human CD8⁺ T-Cell Clones Reactive to Melanoma/Melanocyte Epitope MART1_27–35